{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:29:11Z","timestamp":1790872151124,"version":"4.1.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1097\/md.0000000000011045","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T21:16:04Z","timestamp":1528406164000},"page":"e11045","source":"Crossref","is-referenced-by-count":30,"title":["Successful treatment with tacrolimus in TAFRO syndrome"],"prefix":"10.1097","volume":"97","author":[{"given":"Taiichiro","family":"Shirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Waki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saegusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-62-20210309","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3960\/jslrt.53.63","article-title":"Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly: a clinical report of five cases","volume":"53","author":"Takai","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R2-62-20210309","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1182\/blood-2013-12-545087","article-title":"HHV-8-negative, idiopathic multicentric Castleman disease: Novel insights into biology, pathogenesis, and therapy","volume":"123","author":"Fajgenbaum","year":"2014","journal-title":"Blood"},{"key":"R3-62-20210309","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"R4-62-20210309","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2352-3026(16)00006-5","article-title":"Idiopathic multicentric Castleman's disease: a systematic literature review","volume":"3","author":"Liu","year":"2016","journal-title":"Lancet Haematol"},{"key":"R5-62-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3960\/jslrt.53.79","article-title":"Japanese variant of multicentric Castleman's disease associated with serositis and thrombocytopenia \u2013 A report of two cases: Is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity?","volume":"53","author":"Masaki","year":"2013","journal-title":"J Clin Exp Hematop"},{"key":"R6-62-20210309","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1136\/ard.2011.151092","article-title":"Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients","volume":"70","author":"Koike","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R7-62-20210309","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1007\/s12185-016-1979-1","article-title":"Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version","volume":"103","author":"Masaki","year":"2016","journal-title":"Int J Hematol"},{"key":"R8-62-20210309","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2169\/internalmedicine.55.4710","article-title":"Successful treatment with cyclosporin a in tocilizumab-resistant TAFRO syndrome","volume":"55","author":"Yamaga","year":"2016","journal-title":"Intern Med"},{"key":"R9-62-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1620\/tjem.236.289","article-title":"Successful treatment of TAFRO syndrome, a variant of multicentric Castleman's disease, with cyclosporine A: possible pathogenetic contribution of interleukin-2","volume":"236","author":"Konishi","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"R10-62-20210309","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"R11-62-20210309","first-page":"CD005161","article-title":"Cyclosporin versus tacrolimus for liver transplanted patients","volume":"18","author":"Haddad","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R12-62-20210309","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-6143.2006.01576.x","article-title":"Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: poststudy surveillance to 3 years","volume":"7","author":"Grady","year":"2007","journal-title":"Am J Transpl"},{"key":"R13-62-20210309","first-page":"1433","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Med","year":"1992","journal-title":"Immunol Today"},{"key":"R14-62-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1471-2431-14-139","article-title":"The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman's disease","volume":"14","author":"Kubokawa","year":"2014","journal-title":"BMC Pediatr"},{"key":"R15-62-20210309","doi-asserted-by":"crossref","first-page":"42316","DOI":"10.1038\/srep42316","article-title":"Elevated serum interferon \u03b3-induced protein 10 kDa is associated with TAFRO syndrome","volume":"7","author":"Iwaki","year":"2017","journal-title":"Sci Rep"},{"key":"R16-62-20210309","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"R17-62-20210309","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2177\/jsci.39.64","article-title":"Successful treatment by rituximab in a patient with TAFRO syndrome with cardiomyopathy","volume":"39","author":"Sumie","year":"2016","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"R18-62-20210309","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12185-016-2025-z","article-title":"Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy","volume":"104","author":"Yasuda","year":"2016","journal-title":"Int J Hematol"},{"key":"R19-62-20210309","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1631560","article-title":"Negative inotropic effects of cytokines on the heart mediated by nitric oxide","volume":"257","author":"Finkel","year":"1992","journal-title":"Science"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000011045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:12:55Z","timestamp":1620961975000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201806080-00062"}},"subtitle":["two case reports and literature review"],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":19,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000011045","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}